tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Stan Berenshteyn, 55 are a BUY (49.55%), 6 are a SELL (5.41%), 50 are a HOLD (45.05%).
Analyst Stan Berenshteyn, currently employed at WELLS FARGO, carries an average stock price target met ratio of 62.8% that have a potential upside of 25.5% achieved within 152 days.
Stan Berenshteyn’s has documented 217 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HCAT, Health Catalyst at 12-Aug-2026.
Analyst best performing recommendations are on GDRX (GOODRX HOLDINGS ).
The best stock recommendation documented was for GDRX (GOODRX HOLDINGS ) at 11/9/2022. The price target of $5.5 was fulfilled within 2 days with a profit of $1.44 (35.47%) receiving and performance score of 177.34.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Aug-2022
$45
$9.42 (26.48%)
$49
Buy Since 23-Apr-2026
$50
$14.42 (40.53%)
$55
Buy Since 29-Apr-2026
$65
$29.42 (82.69%)
$70
Buy Since 01-Mar-2023
$60
$19.87 (49.51%)
$50
Which stock is Stan Berenshteyn is most bullish on?
Which stock is Stan Berenshteyn is most reserved on?
What Year was the first public recommendation made by Stan Berenshteyn?
